Proteomic profiling in plasma cell disorders: a feasibility study

Sham MailankodyDepartment of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; ;Department of Medicine, Weill Cornell Medical College, New York, NY, USA;

Sean M. DevlinDepartment of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Neha KordeDepartment of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; ;Department of Medicine, Weill Cornell Medical College, New York, NY, USA;

Nikoletta LendvaiDepartment of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; ;Department of Medicine, Weill Cornell Medical College, New York, NY, USA;

Alexander LesokhinDepartment of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; ;Department of Medicine, Weill Cornell Medical College, New York, NY, USA;

Heather LandauDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA; ;Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Hani HassounDepartment of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; ;Department of Medicine, Weill Cornell Medical College, New York, NY, USA;

Andrea BallagiOlink Proteomics, Uppsala, Sweden;

Daniel EkmanOlink Proteomics, Uppsala, Sweden;

David J. ChungDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA; ;Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Minal PatelSloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Guenther KoehneDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA; ;Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Sergio GiraltDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA; ;Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Ola LandgrenDepartment of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; ;Department of Medicine, Weill Cornell Medical College, New York, NY, USA; Correspondence[email protected]

show all

References

Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113:5412–5417.
PubMed Web of Science ®Google Scholar
Mailankody S, Mena E, Yuan CM, et al. Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma. Leuk Lymphoma. 2010;51:2159–2170.
PubMed Web of Science ®Google Scholar
Cherry BM, Korde N, Kwok M, et al. Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study. Leuk Lymphoma. 2013;54:2215–2218.
PubMed Web of Science ®Google Scholar
Chen H, Zucknick M, Werner S, et al. Head-to-head comparison and evaluation of 92 plasma protein biomarkers for early detection of colorectal cancer in a true screening setting. Clin Cancer Res. 2015;21:3318–3326.
PubMed Web of Science ®Google Scholar
Ebos JM, Lee CR, Bogdanovic E, et al. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Cancer Res. 2008;68:521–529.
PubMed Web of Science ®Google Scholar
Kumar S, Witzig TE, Timm M, et al. Expression of VEGF and its receptors by myeloma cells. Leukemia. 2003;17:2025–2031.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Proteomic profiling in plasma cell disorders: a feasibility study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Proteomic profiling in plasma cell disorders: a feasibility study

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date